Deep Medicine Acquisition...

NASDAQ: DMAQ · Real-Time Price · USD
2.96
-5.43 (-64.72%)
At close: Jan 31, 2024, 10:00 PM

Deep Medicine Acquisition Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Mar 31, 2023 Mar 31, 2022
Revenue
21.86M n/a n/a
Cost of Revenue
7.27M 60K 60K
Gross Profit
14.59M -60K -60K
Operating Income
-2.1M -342.66K -461.65K
Interest Income
106.4K n/a n/a
Pretax Income
-8.8M -342.66K -414.05K
Net Income
-8.8M -400.23K -358.18K
Selling & General & Admin
6.67M 1.91M 409.91K
Research & Development
n/a n/a n/a
Other Expenses
2.75M 200K 60K
Operating Expenses
9.42M 2.11M 409.91K
Interest Expense
-6.93M n/a 8.27K
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
16.69M 2.17M 409.91K
Income Tax Expense
n/a 57.57K -55.87K
Shares Outstanding (Basic)
11.63M 2.31M 8.74M
Shares Outstanding (Diluted)
11.63M 10M 8.74M
EPS (Basic)
-756.01 -0.17 -0.04
EPS (Diluted)
-0.76 -0.04 -0.04
EBITDA
-2.1M -3.99M -405.78K
EBIT
n/a -342.66K -405.78K
Depreciation & Amortization
n/a -3.65M 55.87K